DAFNA Capital Management as of March 31, 2013
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 46 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharmacyclics | 11.1 | $6.8M | 85k | 80.41 | |
| Novadaq Technologies | 8.6 | $5.3M | 535k | 9.91 | |
| Insulet | 6.9 | $4.2M | 164k | 25.86 | |
| Atricure | 6.1 | $3.8M | 477k | 7.92 | |
| Insulet Corp Note 3. 750% 6/1 4 | 5.7 | $3.5M | 3.0M | 1.18 | |
| ARIAD Pharmaceuticals | 5.2 | $3.2M | 176k | 18.08 | |
| Dyax | 5.1 | $3.1M | 720k | 4.36 | |
| Nxstage Medical In | 4.6 | $2.8M | 252k | 11.28 | |
| Given Imaging Ltd ord shs m | 4.1 | $2.6M | 156k | 16.35 | |
| Protalix Biotherapeutics | 3.3 | $2.0M | 367k | 5.49 | |
| Mannkind Corp Note 3.7 50% 12/1 5 | 2.7 | $1.7M | 1.9M | 0.89 | |
| D Rigel Pharmaceutical S Inc Com Common Stock 7 | 2.4 | $1.5M | 216k | 6.80 | |
| Cardica | 2.3 | $1.4M | 1.1M | 1.30 | |
| Xenoport | 2.2 | $1.4M | 191k | 7.15 | |
| Cardionet | 2.1 | $1.3M | 538k | 2.43 | |
| Cutera | 1.9 | $1.2M | 91k | 13.00 | |
| D Achillion Pharmaceuticals Inc. Common Stock 0 | 1.6 | $1.0M | 117k | 8.75 | |
| DISCOVERY Laboratories | 1.6 | $984k | 430k | 2.29 | |
| Nuvasive Inc Note 2. 750% 7/0 6 | 1.6 | $970k | 1.0M | 0.97 | |
| Spectranetics | 1.6 | $970k | 52k | 18.52 | |
| Syneron Medical Ltd ord shs m | 1.5 | $929k | 91k | 10.21 | |
| Biospecifics Tech | 1.4 | $881k | 52k | 17.04 | |
| Rti Biologics | 1.4 | $853k | 217k | 3.93 | |
| SH BEN INT Infusystem Hldgs | 1.3 | $826k | 475k | 1.74 | |
| Johnson & Johnson | 1.2 | $766k | 9.4k | 81.49 | |
| Trans1 | 1.2 | $753k | 336k | 2.24 | |
| Uroplasty | 1.2 | $720k | 289k | 2.49 | |
| Exactech | 1.1 | $696k | 34k | 20.69 | |
| Immunomedics | 1.1 | $699k | 290k | 2.41 | |
| Derma Sciences Inc Com par $.01 2 | 1.1 | $689k | 57k | 12.09 | |
| Keryx Biopharmaceuticals C om 4 | 0.9 | $542k | 77k | 7.04 | |
| Dynavax Technologies | 0.8 | $507k | 228k | 2.22 | |
| D Vertex Pharmaceutica Ls Inc Co Common Stock 9 | 0.8 | $473k | 8.6k | 55.00 | |
| Curis | 0.7 | $409k | 125k | 3.28 | |
| Stereotaxis Inc C ommon stock 8 | 0.6 | $353k | 177k | 2.00 | |
| Masimo Corporation | 0.6 | $343k | 18k | 19.60 | |
| Digirad | 0.5 | $320k | 127k | 2.52 | |
| Theragenics Corp | 0.4 | $262k | 161k | 1.63 | |
| Lpath | 0.4 | $247k | 49k | 5.03 | |
| Graymark Healthcare Inc Com Pa r $.0001 3 | 0.4 | $243k | 693k | 0.35 | |
| Palatin Technologies Inc Com par $.01 6 | 0.3 | $178k | 297k | 0.60 | |
| Enteromedics | 0.1 | $82k | 82k | 1.00 | |
| Neurometrix Inc Com Par $0.0001 6 | 0.1 | $82k | 33k | 2.48 | |
| Trovagene Inc *w Exp 9 9/99/999 8 | 0.1 | $70k | 30k | 2.36 | |
| Inovio Pharmaceuticals | 0.1 | $38k | 64k | 0.60 | |
| Combimatrix Corp *w Exp 0 5/01/201 2 | 0.0 | $999.750000 | 2.3k | 0.43 |
